Apparently the CD47 block alone is insufficient for tumor growth retardation, which is in accordance with the findings of Weisskopf et al.: while applying the CD47-blocking protein CV1 monomer alone, no reduction of tumor growth in vivo was observed. Here, CD47 is linked to neoplasm.